Schizophrenia In Adolescents
Article updated and reviewed by Christos Ballas, MD, Attenting Psychiatrist, Inpatient and Consult/Liaison Psychiatry, Hospital of the University of Pennsylvania. Editorial review provided by VeriMed Healthcare Network on May 11, 2005.
More information on "Schizophrenia In Adolescents"
From Our Experts
FDA Approves Risperdal for the Treatment of Schizophrenia and Bipolar...
The approval by the FDA for the use of Risperdal in the treatment of schizophrenia and bipolar disorder in children is a momentous event.... Read more »
A New Indication for Abilify
Recently, the medication Abilify (aripiprazole) was approved by the FDA for the treatment of schizophrenia in the adolescent population... Read more »
FDA Approves Risperdal for Children and Adolescents: a Good Move?
Today, the FDA approved Risperdal for the treatment of schizophrenia in adolescents 13 to 17 years old and for the short-term (three week)... Read more »
FDA Greenlights Risperdal for Kids and Teens
The FDA approved Risperdal for the treatment of schizophrenia or bipolar I disorder in kids and teens. Risperdal can now be prescribed for... Read more »
Drugs Prescribed for Bipolar Disorder: Risperdal (Risperidone)
Risperdal - generic risperidone - is an antipsychotic medication. It's approved as a treatment for schizophrenia (adults and adolescents... Read more »
From Our Sources
Clinical trial: Geodon and teen schizophrenia
This is a study to determine if flexibly-dosed Geodon is a safe and effective treatment for adolescents with schizophrenia. This international study... Read more »
Adolescent depression
Source: ADAM Encyclopedia
Depression - adolescents; Teenage depressionSymptomsDepression can change the way teenagers see themselves, their lives, and the people around them.... Read more »
Clinical trial: Invega XR dosing for teens with schizophrenia
This is a study to evaluate the long-term safety and effectiveness of Invega XR, given in flexible doses, to teens with schizophrenia. This national... Read more »
Clinical trial: Extended-release Invega for teens with schizop...
This is a study to evaluate the long-term safety and tolerability of flexible doses of extended-release Invega in teens who have been diagnosed with... Read more »
Schizophrenia: Introduction
Source: ADAM Encyclopedia
of SchizophreniaSchizophrenia can have a devastating impact on patients and their families. Patients with schizophrenia have increased risk for... Read more »
Featuring Content From:
By using this service, you accept our Terms of Use. Please read them. The consumer health information on is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen. Copyright © 2012 Remedy Health Media, LLC. All Rights Reserved.
